Saturday 6 December 2025
Home      All news      Contact us      RSS     
globalnews - 28 days ago

Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

NEW YORK (AP) — U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind weight-loss treatments Ozempic and Wegovy.


Latest News
Hashtags:   

Pfizer

 | 

clinches

 | 

obesity

 | 

developer

 | 

Metsea

 | 

after

 | 

bidding

 | 

Nordisk

 | 

Sources